1. Home
  2. RLI vs KRYS Comparison

RLI vs KRYS Comparison

Compare RLI & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

N/A

Current Price

$61.14

Market Cap

5.4B

Sector

Finance

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$259.18

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RLI
KRYS
Founded
1965
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
7.8B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
RLI
KRYS
Price
$61.14
$259.18
Analyst Decision
Hold
Strong Buy
Analyst Count
7
10
Target Price
$66.00
$297.60
AVG Volume (30 Days)
701.3K
260.4K
Earning Date
04-22-2026
05-18-2026
Dividend Yield
4.28%
N/A
EPS Growth
16.84
128.00
EPS
4.37
6.84
Revenue
$1,882,448,000.00
$389,130,000.00
Revenue This Year
N/A
$40.88
Revenue Next Year
$3.53
$35.16
P/E Ratio
$14.15
$37.15
Revenue Growth
6.33
33.94
52 Week Low
$55.80
$123.03
52 Week High
$81.79
$298.30

Technical Indicators

Market Signals
Indicator
RLI
KRYS
Relative Strength Index (RSI) 48.96 44.51
Support Level $60.44 $255.65
Resistance Level $65.43 $293.60
Average True Range (ATR) 1.30 11.12
MACD -0.02 -2.10
Stochastic Oscillator 36.86 20.44

Price Performance

Historical Comparison
RLI
KRYS

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: